Back to News
Market Impact: 0.15
Cramer Says It's Time To Buy The Dip on JNJ
Source: 247wallst.com
Analyst InsightsHealthcare & BiotechInvestor Sentiment & Positioning
Jim Cramer urged investors to buy Johnson & Johnson shares during a mid-session decline, expressing a positive near-term view on the stock. The commentary may modestly support retail investor sentiment but does not include new company fundamentals, earnings, or guidance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
JNJ0.35
More News
- Kura Oncology at Wells Fargo conference: launch gains and pipeline breadth
- Protagonist Therapeutics authorizes $300 million buyback plan
- Protagonist Therapeutics Announces $300 Million Share Repurchase Program
- Medtronic at Wells Fargo healthcare conference: growth broadens
- Enovis at Wells Fargo healthcare conference: robotics push takes center stage
- Nvidia Earnings Blow Everyone Away